Join to View Full Profile
525 E 68th St# 69New York, NY 10065
Phone+1 646-253-2808
Fax+1 212-746-3856
Dr. Cesarman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1988 - 1992
Autonomous Metropolitan University XochimilcoClass of 1981
Certifications & Licensure
NY State Medical License 1991 - 2025
American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2001
Publications & Presentations
PubMed
- Automated Detection of Kaposi Sarcoma-Associated Herpesvirus-Infected Cells in Immunohistochemical Images of Skin Biopsies.Iftak Hussain, Juan Boza, Robert Lukande, Racheal Ayanga, Aggrey Semeere
JCO Global Oncology. 2025-04-01 - Integrative Functional Genomics Analysis of Kaposi Sarcoma Cohorts.Ezequiel Lacunza, Valeria Fink, Julian Naipauer, María E Salas, Ana M Gun
Research Square. 2025-03-11 - T Cells Spatially Regulate B Cell Receptor Signaling in Lymphomas through H3K9me3 Modifications.Lucy S Britto, Deepali Balasubramani, Sona Desai, Phunterion Phillips, Neev Trehan
Advanced Healthcare Materials. 2025-02-01
Abstracts/Posters
- Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's LymphomaEthel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085Ethel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL SubtypesEthel Cesarman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Weill Cornell Medicine Awarded NCI Grant for EBV-Related Lymphoma ResearchFebruary 23rd, 2023- Portable Diagnostic Device Helps African Physicians Diagnose CancerAugust 24th, 2022
TINY Cancer Detection Device Proves Effective in Uganda TestingSeptember 12th, 2018
Grant Support
- Weill Cornell Initiative for Maximizing Student DevelopmentWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
- Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
- Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
- Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
- Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
- Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
- Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)WEILL MEDICAL COLL OF CORNELL UNIV2023–2028
- Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETECORNELL UNIVERSITY2022–2027
- B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- Next-Gen Oncopathology ProgramWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- B cell determinants of EBV latencyWEILL MEDICAL COLL OF CORNELL UNIV2022–2027
- Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
- Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
- Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
- Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
- Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
- Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in LymphomaFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2021–2026
- (PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
- (PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
- (PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
- (PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
- (PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
- (PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
- (PQ 6) New Models of KSHV Oncogenesis and KS Immune EnvironmentWEILL MEDICAL COLL OF CORNELL UNIV2020–2025
- Role of novel onco-histone mutations in B-cell malignanciesWEILL MEDICAL COLL OF CORNELL UNIV2019–2025
- Weill Cornell Initiative for Maximizing Student DevelopmentWEILL MEDICAL COLL OF CORNELL UNIV2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
